Biology and significance of circulating and disseminated tumour cells in colorectal cancer

Langenbeck's Archives of Surgery

Volumn 397, Issue 4, 2012, Pages 535-542

  Steinert, Gunnar ^a   Schölch, Sebastian ^a   Koch, Moritz ^a   Weitz, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Circulating tumour cells; Clinical significance; Colorectal cancer; Disseminated tumour cells; Epithelial mesenchymal transition; Prognostic value

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 18 FRAGMENT M30; CYTOKERATIN 18 FRAGMENT M65; CYTOKERATIN 20; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; UNCLASSIFIED DRUG;

BONE MARROW; CANCER RESISTANCE; CANCER STEM CELL; CELL AGGREGATION; CELL HOMING; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CIRCULATING TUMOR CELL; COLORECTAL CANCER; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; LYMPH NODE; METASTASIS; NONHUMAN; ONCOGENE K RAS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TP53 GENE;

ANIMALS; BONE MARROW NEOPLASMS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863892963     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0917-9     Document Type: Review

References (111)

1. Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448-456 (Pubitemid 38745530)
2. Wolfrum F et al (2005) Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. Langenbecks Arch Surg 390(5):430-441 (Pubitemid 41253177)
3. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46 (4):765-781
4. Thorsteinsson M, Jess P (2011) The clinical significance of circulating tumor cells in non-metastatic colorectal cancer-a review. Eur J Surg Oncol 37(6):459-465
5. Weitz J et al (2005) Colorectal cancer. Lancet 365(9454):153-165 (Pubitemid 40091806)
6. Hess KR et al (2006) Metastatic patterns in adenocarcinoma. Cancer 106(7):1624-1633
7. Ashworth, TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14:146-7
8. Zhan M, Zhao H, Han ZC (2004) Signalling mechanisms of anoikis. Histol Histopathol 19(3):973-983 (Pubitemid 38855077)
9. Sachdev D et al (2010) The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene 29(2):251-262
10. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6):453-458 (Pubitemid 37328849)
11. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559-1564
12. Thiery JP et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890
13. Sun YF et al (2011) Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 137(8):1151-1173
14. Yang J,Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14 (6):818-829 (Pubitemid 351757205)
15. Morel AP et al (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3(8):e2888
16. Sabbah M et al (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11(4-5):123-151
17. Vincan E et al (2007) A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis. Cells Tissues Organs 185(1-3):20-28 (Pubitemid 46956839)
18. Loboda A et al (2011) EMT is the dominant program in human colon cancer. BMC Med Genomics 4:9
19. Lecharpentier A et al (2011) Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 105(9):1338-1341
20. Hiratsuka S et al (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8(12):1369-1375 (Pubitemid 44835111)
21. Kang SY et al (2009) Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. Proc Natl Acad Sci U S A 106(29):12115-12120
22. Kaplan RN et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (7069):820-827 (Pubitemid 41753060)
23. Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6(6):449-458
24. Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159-211 (Pubitemid 20088338)
25. Gout S, Tremblay PL, Huot J (2008) Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis 25(4):335-344 (Pubitemid 351752950)
26. Camerer E et al (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104(2):397-401 (Pubitemid 38900020)
27. Nieswandt B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59 (6):1295-1300 (Pubitemid 29136261)
28. Hou JM et al (2011) Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 178(3):989-996
29. Pawelek JM, Chakraborty AK (2008) The cancer cell-leukocyte fusion theory of metastasis. Adv Cancer Res 101:397-444
30. Abdel-Ghany M et al (2001) The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis. J Biol Chem 276(27):25438-25446
31. Brown DM, Ruoslahti E (2004) Metadherin, a cell surface protein in breast tumors thatmediates lungmetastasis. Cancer Cell 5(4):365-374 (Pubitemid 38482072)
32. Wang H et al (2004) Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 164 (6):935-941 (Pubitemid 38366904)
33. Kim MY et al (2009) Tumor self-seeding by circulating cancer cells. Cell 139(7):1315-1326
34. Chang YS et al (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 97(26):14608-14613 (Pubitemid 32016623)
35. Brooks DE (1984) The biorheology of tumor cells. Biorheology 21(1-2):85-91 (Pubitemid 14051587)
36. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8(5):329-340 (Pubitemid 351596394)
37. Smirnov DA et al (2005) Global gene expression profiling of circulating tumor cells. Cancer Res 65(12):4993-4997 (Pubitemid 40827303)
38. Solmi R et al (2006) Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. BMC Cancer 6:250
39. Zieglschmid V et al (2007) Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer. Anticancer Res 27(4A):1823-1832 (Pubitemid 46954682)
40. Lankiewicz S et al (2008) Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell Oncol 30(6):463-471
41. Lankiewicz S et al (2008) Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer. Mol Oncol 2(4):349-355
42. Findeisen P et al (2008) Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients. Int J Oncol 33 (5):1001-1010
43. Gazzaniga P et al (2010) Molecular markers in circulating tumour cells from metastatic colorectal cancer patients. J Cell Mol Med 14(8):2073-2077
44. Wong SC et al (2011) Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients. Br J Cancer 104(6):1000-1006
45. Xi L et al (2007) Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem 53(7):1206-1215 (Pubitemid 47020975)
46. Riethdorf S, Wikman H, Pantel K (2008) Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 123(9):1991-2006
47. Klein CA et al (2002) Genetic heterogeneity of single disseminated tumour cells inminimal residual cancer. Lancet 360(9334):683-689 (Pubitemid 35232337)
48. Stoecklein NH, Klein CA (2010) Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer 126(3):589-598
49. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9(4):302-312
50. Weber JC et al (2007) Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes. Int J Cancer 120(3):524-532
51. Conzelmann M, Linnemann U, Berger MR (2005) Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis 20(2):137-146 (Pubitemid 40227520)
52. Kraus MC, Linnemann U, Berger MR (2011) Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays. Oncol Rep 25(5):1421-1429
53. Tortola S et al (2001) Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J Clin Oncol 19(11):2837-2843 (Pubitemid 32538192)
54. Braun S et al (2000) Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18(1):80-86 (Pubitemid 30036339)
55. Wikman H, Vessella R, Pantel K (2008) Cancer micrometastasis and tumour dormancy. APMIS 116(7-8):754-770
56. Sosa MS et al (2011) ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res 17(18):5850-5857
57. Alencar H et al (2005) A novel mouse model for segmental orthotopic colon cancer. Int J Cancer 117(3):335-339 (Pubitemid 41429555)
58. Bhullar JS et al (2011) A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation. J Am Coll Surg 213(1):54-60, discussion 60-1
59. Bresalier RS et al (1987) An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Cancer Res 47(5):1398-1406 (Pubitemid 17023214)
60. Donigan M et al (2010) A metastatic colon cancer model using nonoperative transanal rectal injection. Surg Endosc 24(3):642-647
61. Eliane JP et al (2008) Monitoring serial changes in circulating human breast cancer cells in murine xenograft models. Cancer Res 68(14):5529-5532
62. Fu XY et al (1991) Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci U S A 88(20):9345-9349
63. Galanzha EI et al (2009) In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res 69(20):7926-7934
64. Kolostova K et al (2011) Circulating human prostate cancer cells from an orthotopic mouse model rapidly captured by immunomagnetic beads and imaged by GFP expression. Anticancer Res 31(5):1535-1539
65. Lupu CM et al (2006) An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. J Gastrointest Surg 10 (5):635-645 (Pubitemid 43711146)
66. Zigmond E et al (2011) Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer. PLoS One 6(12):e28858
67. Peach G et al (2010) Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br J Cancer 102(9):1327-1334
68. Rahbari NN et al (2010) Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138(5):1714-1726
69. Weitz J et al (1998) Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 4 (2):343-348 (Pubitemid 28122748)
70. Bessa X et al (2001) Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 120(5):1084-1092 (Pubitemid 32246662)
71. Bessa X et al (2003) Prognostic value of postoperative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure. Ann Surg 237(3):368-375 (Pubitemid 38176452)
72. Bosch B et al (2003) Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 90(7):882-888 (Pubitemid 36886394)
73. Koch M et al (2005) Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg 241 (2):199-205
74. Allen-Mersh TG et al (2007) Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 94(1):96-105 (Pubitemid 46142739)
75. Koyanagi K et al (2008) Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 14(22):7391-7396
76. Uen YH et al (2008) Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol 15 (8):2120-2128
77. AllardWJ et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897-6904 (Pubitemid 39383039)
78. Negin BP, Cohen SJ (2010) Circulating tumor cells in colorectal cancer: past, present, and future challenges. Curr Treat Options Oncol 11(1-2):1-13
79. Cohen SJ et al (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26(19):3213-3221
80. Cohen SJ et al (2009) Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20(7):1223-1229
81. Tol J et al (2008) A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in firstline advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity. Ann Oncol 19(4):734-738 (Pubitemid 351461045)
82. Wong SC et al (2009) Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res 15(3):1005-1012
83. Lindemann F et al (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340(8821):685-689
84. Pantel K et al (1996) Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-smallcell lung cancer without overtmetastases. Lancet 347(9002):649-653 (Pubitemid 26076131)
85. Leinung S et al (2000) Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma. Langenbecks Arch Surg 385(5):337-343
86. Broll R et al (1996) Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma. Langenbecks Arch Chir 381(1):51-58
87. Cohen AM et al (1998) In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases. Dis Colon Rectum 41(9):1112-1115 (Pubitemid 28432451)
88. Juhl H et al (1994) Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57(3):330-335 (Pubitemid 24168605)
89. Schott A et al (1998) Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 227(3):372-379 (Pubitemid 28131018)
90. Flatmark K et al (2002) Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients. Clin Cancer Res 8(2):444-449 (Pubitemid 34193963)
91. Pantel K et al (1994) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3(3):165-173
92. Schoppmeyer K et al (2006) Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases. Oncol Rep 15(2):449-454
93. O'Sullivan GC et al (1997) Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 40(4):512-515
94. Leinung S et al (2000) Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis. J Hematother Stem Cell Res 9 (6):905-911 (Pubitemid 32110291)
95. Vlems FA et al (2003) Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg 90(8):989-995 (Pubitemid 37026329)
96. Soeth E et al (1996) The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 69(4):278-282 (Pubitemid 26298291)
97. Soeth E et al (1997) Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57(15):3106-3110 (Pubitemid 27351719)
98. Gerhard M et al (1994) Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12(4):725-729 (Pubitemid 24110911)
99. Conzelmann M et al (2003) Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients. Int J Cancer 107(4):617-628 (Pubitemid 37296124)
100. Ausch C et al (2009) Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients. J Gastrointest Surg 13(11):2020-2026
101. Buergy D et al (2009) Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer. Cancer 115(20):4667-4678
102. Vogelaar FJ et al (2010) Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study. BMC Cancer 10:153
103. Buxhofer-Ausch V et al (2010) Spontaneous changes in tumour cell dissemination to bone marrow in colorectal cancer. Colorectal Dis 12(8):776-782
104. Valladares-Ayerbes M et al (2011) Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer. Int J Oncol 39(5):1253-1264
105. Greenson JK et al (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73(3):563-569 (Pubitemid 24046594)
106. Nakanishi Y et al (1999) Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology 57(4):276-280
107. Oberg A et al (1998) Are lymph node micrometastases of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 41(10):1244-1249 (Pubitemid 28477972)
108. Weitz J et al (1999) Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5 (7):1830-1836 (Pubitemid 29334465)
109. Rosenberg R et al (2004) Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 19(5):430-437 (Pubitemid 39193808)
110. Conzelmann M, Linnemann U, Berger MR (2004) K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Int J Oncol 24 (6):1537-1544
111. Rahbari NN, Bork U,Motschall E, Thorlund K, BüchlerMW, Koch M, Weitz J (2012) Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and metaanalysis. J Clin Oncol 30(1):60-70. doi:10.1200/JCO.2011.36.9504